Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides

By sjmartinez • July 1, 2025

Murugesan P, Zhang Y, Zhang Y, Youn JY, Cai H. Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides. Redox Biol. 2025 Jun 13;85:103710. doi: 10.1016/j.redox.2025.103710. Epub ahead of print. PMID: 40580754.

Tags: Cardiology/Epi, Endothelial nitric oxide synthase uncoupling, eNOS, hypoxia, Mitochondrial superoxide production, Netrin-1, Netrin-1 derived small peptides, NO bioavailability, Publications, pulmonary hypertension, Pulmonary vascular remodeling, reactive oxygen species, Right ventricular hypertrophy, ROS, Translational

Related Posts

Ethnic differences in coronary plaque burden and characteristics: A matched CCTA cohort study of South Asians and non-Hispanic Whites

Manubolu VS, Kinninger A, Lakshmanan S, Dahal S, Ichikawa K, Verghese D, Alalawi L, Aldana J, Susarla S, Seok HJ, Dailing C, Roy SK, Rohatgi[...]

Biomimetic, Suturable, and Extensible Electrospun Scaffolds for Lower Urinary Tract Surgical Reconstruction

Sturm RM, Huo Y, Yiu F, Gu Y, Afshari R, Zhong Z, Jimenez R, Jung R, Cabuan A, Shukla K, Harrison K, Su J, Aninwene[...]

Machine learning-assisted point-of-care diagnostics for cardiovascular healthcare

Wang K, Tan B, Wang X, Qiu S, Zhang Q, Wang S, Yen YT, Jing N, Liu C, Chen X, Liu S, Yu Y. Machine[...]